Cargando…
Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
BACKGROUND: Psoriasis is a chronic and currently incurable inflammatory skin disease characterized by hyperproliferation, aberrant differentiation, and inflammation, leading to disrupted skin barrier function. The use of natural agents that can abrogate these effects could be useful for the treatmen...
Autores principales: | Chamcheu, Jean Christopher, Siddiqui, Imtiaz A, Adhami, Vaqar M, Esnault, Stephane, Bharali, Dhruba J, Babatunde, Abiola S, Adame, Stephanie, Massey, Randall J, Wood, Gary S, Longley, B Jack, Mousa, Shaker A, Mukhtar, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059258/ https://www.ncbi.nlm.nih.gov/pubmed/30057446 http://dx.doi.org/10.2147/IJN.S165966 |
Ejemplares similares
-
Chitosan-Based Nanoformulated (–)-Epigallocatechin-3-Gallate (EGCG) Modulates Human Keratinocyte-Induced Responses and Alleviates Imiquimod-Induced Murine Psoriasiform Dermatitis [Erratum]
Publicado: (2023) -
Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
por: Sanna, Vanna, et al.
Publicado: (2017) -
Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects
por: Bharali, Dhruba J., et al.
Publicado: (2011) -
Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice
por: Zhang, Shuangshuang, et al.
Publicado: (2016) -
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)